Nanoform and Aprecia collaborate to advance 3D printed Nanomedicines
Nanoform and Aprecia collaborate to advance 3D printed Nanomedicines News provided by Share this article Share this article HELSINKI, April 21, 2021 /PRNewswire/ -- Nanoform Finland Plc, an innovative nanoparticle medicine enabling company, and Aprecia, the 3DP (three-dimensional printing) pharmaceutical company, announce that they are exploring the synergies between their respective technologies in the field of nanoparticle-enabled 3DP dosage forms. This collaboration seeks to provide customers and the pharmaceutical industry with new capabilities in patient centric therapies. The immediat...